Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Few Blockbusters So Far From China’s First-In-Class Innovation
Mixed Fortunes For Pioneers
Dec 17 2024
•
By
Dexter Jie Yan
Since 2019, a total of ten Chinese homegrown first-in-class drugs have hit the road of commercialization. • Source: Shutterstock
More from China
More from Scrip